查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
非荷尔蒙避孕市场规模、份额和成长分析（按方法、性别、可用性、年龄层、分销管道、最终用户和地区划分）—产业预测（2026-2033 年）
市场调查报告书
商品编码
1897955

非荷尔蒙避孕市场规模、份额和成长分析（按方法、性别、可用性、年龄层、分销管道、最终用户和地区划分）—产业预测（2026-2033 年）

Non-Hormonal Contraception Market Size, Share, and Growth Analysis, By Method (Barrier Method, Spermicidal), By Gender (Male, Female), By Accessibility, By Age Group, By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年，全球非荷尔蒙避孕市场规模将达到 326.6 亿美元，到 2025 年将成长至 347.9 亿美元，到 2033 年将成长至 575.7 亿美元，预测期（2026-2033 年）的复合年增长率为 6.5%。

全球非荷尔蒙避孕市场涵盖多种无需依赖荷尔蒙即可有效阻止受精和着床的方法。主要类别包括屏障法，例如男用和女性用保险套、隔膜和子宫颈帽。这些方法在精子和卵子之间形成物理屏障，其特点是易于取得且副作用极小。此外，基于月经週期的方法，例如基础体温监测，利用月经週期追踪来识别排卵期，但需要精确监测才能有效。非荷尔蒙避孕方法，例如子宫内避孕器（IUD），特别是含铜子宫内避孕器，提供了一种长期解决方案，可以阻止受精并减少日常管理。虽然它们非常有效，但也面临一些挑战，例如需要持续使用以及放置过程中可能出现的不适，这凸显了使用者教育和医疗保健指导对于最大限度地提高其有效性的重要性。

推动全球非荷尔蒙避孕市场发展的因素

推动全球非荷尔蒙避孕市场发展的关键因素之一是人们对避孕方法的认知不断提高。随着越来越多的人重视计划生育并寻求安全有效的避孕方法，非荷尔蒙避孕方式的使用率显着上升。取得教育资源和咨询服务对于提高消费者对各种避孕方法的了解至关重要，从而增强了他们对非荷尔蒙製剂的偏好。这种需求促使生产者开发创新非荷尔蒙避孕产品，以满足消费者多样化的需求，他们越来越倾向选择符合自身健康偏好和生活方式的产品。

全球非荷尔蒙避孕市场面临的限制因素

全球非荷尔蒙避孕市场面临许多挑战，尤其是在发展中地区，这些地区的避孕途径和认知度都十分有限。基础设施和资源的匮乏阻碍了非荷尔蒙避孕方法的广泛应用，也阻碍了有效避孕的普及。此外，不同社区的文化和宗教信仰也加剧了人们对避孕器的抗拒情绪，进一步阻碍了市场扩张。这些因素不仅导致意外怀孕率上升，也导致性行为感染感染率升高，最终阻碍了非荷尔蒙避孕市场的成长前景。因此，消除这些障碍对于建立一个更强大、更容易获得的市场至关重要。

全球非荷尔蒙避孕药市场趋势

全球非荷尔蒙避孕市场正经历一个显着趋势：消费者对天然有机避孕方案的需求日益增长。随着消费者对荷尔蒙避孕药潜在副作用的认识不断提高，他们正积极寻求不含合成荷尔蒙或化学物质的替代方案。这种转变推动了非荷尔蒙避孕方法的普及，包括传统保险套和各种天然计划生育方法，这些方法被认为更安全、更环保。此外，消费者对永续性和环保意识的日益增强也持续推动着这一趋势，他们优先考虑符合自身健康和环保价值观的产品。

目录

介绍

  • 调查目标
  • 市场定义和范围

调查方法

  • 调查过程
  • 一手和二手资料方法
  • 市场规模估算方法
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 主要市场亮点
  • 行业概览
  • 竞争格局概述

市场动态与展望

  • 总体经济指标
  • 驱动因素和机会
  • 限制与挑战
  • 供给面趋势
  • 需求面趋势
  • 波特的分析和影响

关键市场考察

  • 关键成功因素
  • 市场影响指数
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数
  • 临床实验室分析
  • 专利分析
  • 用例分析
  • PESTEL 分析
  • 监管分析
  • 管道分析
  • 技术分析
  • 基础体温法使用者

全球非荷尔蒙避孕方法市场（2019-2032 年）

  • 屏障法
    • 保险套
    • 男性
    • 女士
    • 子宫托
    • 子宫颈帽
    • 非荷尔蒙子宫内避孕器
    • 避孕海绵
    • 其他设备
  • 杀精剂
  • 节育手术
    • 男性节育手术（切除术）
    • 无刀输精管切除术
    • 传统切除术
    • 微创输精管切除术
    • 女性节育手术（输卵管结扎）
    • 腹腔镜输卵管结扎术
    • 子宫镜输卵管结扎术
    • 微创手术
    • 其他输卵管手术
  • 其他方法

全球非荷尔蒙避孕市场规模（按性别划分）（2019-2032 年）

  • 男性
  • 女士

全球非荷尔蒙避孕市场规模（依性别划分）及供应情况（2019-2032 年）

  • 非处方药
  • 处方笺

全球非荷尔蒙避孕市场按年龄层划分（2019-2032 年）

  • 13至19岁
  • 20-29岁
  • 30-39岁
  • 40岁或以上

全球非荷尔蒙避孕市场依通路划分（2019-2032 年）

  • 医院药房
  • 零售药房
  • 线上平台
  • 政府和非政府组织分发管道
  • 其他的

全球非荷尔蒙避孕市场规模（依最终用户划分）（2019-2032 年）

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

全球非荷尔蒙避孕市场规模（2019-2032 年）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东和非洲
    • GCC
    • 南非
    • 其他中东和非洲地区

竞争对手仪錶板

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）

主要企业简介

  • Evofem Biosciences
  • Dare Bioscience
  • CooperSurgical（Cooper Co.）
  • Reckitt Benckiser
  • Trojan
  • Mayer Laboratories Inc.
  • LifeStyles Healthcare
  • Kessel Medintim GmbH
  • Contraline, Inc.
  • YourChoice Therapeutics
  • Contrel Europe
  • NEXT Life Sciences
  • Femasys Inc.
  • Apothecus Pharmaceutical
  • Sebela Pharmaceuticals（Sebela Women's Health）
  • FemCap Inc.
  • Mona Lisa NV
  • Okamoto Industries, Inc.
  • Fuji Latex Co., Ltd.
  • Veru Inc.

结论和分析师建议

简介目录
Product Code: SQMIG35D2065

Global Non-Hormonal Contraception Market size was valued at USD 32.66 Billion in 2024 and is poised to grow from USD 34.79 Billion in 2025 to USD 57.57 Billion by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

The global market for non-hormonal contraception encompasses various methods that effectively prevent fertilization or implantation without relying on hormones. Key categories include barrier methods, such as male and female condoms, diaphragms, and cervical caps, which create a physical barrier between sperm and egg and are known for their wide availability and minimal side effects. Additionally, fertility awareness-based methods utilize menstrual cycle tracking to identify fertile windows, requiring precise monitoring for effectiveness. Intrauterine devices (IUDs), specifically non-hormonal types like copper IUDs, offer a long-lasting solution by preventing fertilization and requiring less daily management. Although highly effective, such methods face challenges like the need for consistent use and potential discomfort during insertion, highlighting the importance of user education and healthcare guidance in maximizing their effectiveness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Hormonal Contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segments Analysis

Global Non-Hormonal Contraception Market is segmented by Method, Gender, Accessibility, Age Group, Distribution Channel, End User and region. Based on Method, the market is segmented into Barrier Method, Spermicidal, Sterilization and Other Methods. Based on Gender, the market is segmented into Male and Female. Based on Accessibility, the market is segmented into Over-the-Counter (OTC) and Prescription-Based. Based on Age Group, the market is segmented into 13-19 Years, 20-29 Years, 30-39 Years and 40+ Years. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Platforms, Government & NGO Distribution Channels and Others. Based on End User, the market is segmented into Hospital, Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Hormonal Contraception Market

A significant factor driving the global non-hormonal contraception market is the rising awareness surrounding contraceptive options. As more individuals prioritize family planning and search for safe and effective methods, there is a notable shift towards non-hormonal alternatives. Access to educational resources and counseling services has played a vital role in enhancing consumer knowledge about various contraceptive methods, leading to an increased preference for non-hormonal solutions. This demand has prompted manufacturers to focus on developing innovative non-hormonal contraceptive products that cater to the diverse needs of consumers, who increasingly seek options that align with their health preferences and lifestyle choices.

Restraints in the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market encounters significant challenges, particularly in developing regions where access and awareness are considerably limited. Inadequate infrastructure and resources restrict the availability of non-hormonal contraceptive options, creating barriers to effective contraception. Furthermore, cultural and religious beliefs in various communities contribute to the reluctance surrounding contraceptive use, further complicating market expansion. These factors not only lead to increased instances of unintended pregnancies but also elevate the rates of sexually transmitted infections, which ultimately stymie the growth prospects for the non-hormonal contraception market. Addressing these obstacles is essential for fostering a more robust and accessible market.

Market Trends of the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market is witnessing a notable trend towards the rising demand for natural and organic contraceptive solutions. As consumers become increasingly educated about the potential adverse effects of hormonal contraceptives, they are actively seeking alternatives that are devoid of synthetic hormones and chemicals. This shift is fostering the popularity of non-hormonal options, including traditional condoms and various natural family planning methods, which are viewed as safer and more environmentally friendly. Furthermore, the growing emphasis on sustainability and eco-consciousness continues to propel this trend, as consumers prioritize products that align with their health and environmental values.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impact Factor
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index
  • Clinical Trial Analysis
  • Patent Analysis
  • Case Study Analysis
  • PESTEL Analysis
  • Regulatory Analysis
  • Pipeline Analysis
  • Technology Analysis
  • Fertility Awareness Method Users

Global Non-Hormonal Contraception Market Size by Method (Value/Volume) (2019-2032)

  • Market Overview
  • Barrier Method
    • Condoms
    • Male
    • Female
    • Diaphragms
    • Cervical Caps
    • Non-Hormonal IUDs
    • Contraceptive Sponges
    • Other Devices
  • Spermicidal
  • Sterilization
    • Male Sterilization (Vasectomy)
    • No-scalpel Vasectomy
    • Conventional Vasectomy
    • Minimally Invasive Vasectomy
    • Female Sterilization (Tubal Ligation)
    • Laparoscopic Tubal Ligation
    • Hysteroscopic Tubal Ligation
    • Mini-Laparotomy
    • Other Tubal Procedures
  • Other Methods

Global Non-Hormonal Contraception Market Size by Gender (2019-2032)

  • Market Overview
  • Male
  • Female

Global Non-Hormonal Contraception Market Size by Accessibility (2019-2032)

  • Market Overview
  • Over-the-Counter (OTC)
  • Prescription-Based

Global Non-Hormonal Contraception Market Size by Age Group (2019-2032)

  • Market Overview
  • 13-19 Years
  • 20-29 Years
  • 30-39 Years
  • 40+ Years

Global Non-Hormonal Contraception Market Size by Distribution Channel (2019-2032)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms
  • Government & NGO Distribution Channels
  • Others

Global Non-Hormonal Contraception Market Size by End-User (2019-2032)

  • Market Overview
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Global Non-Hormonal Contraception Market Size (2019-2032)

  • North America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
    • US
    • Canada
  • Europe (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Dashboard

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025

Key Company Profiles

  • Evofem Biosciences
    • Company Overview
    • Product Portfolio Overview
    • Financial Overview
    • Key Developments
  • The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
  • Dare Bioscience
  • CooperSurgical (Cooper Co.)
  • Reckitt Benckiser
  • Trojan
  • Mayer Laboratories Inc.
  • LifeStyles Healthcare
  • Kessel Medintim GmbH
  • Contraline, Inc.
  • YourChoice Therapeutics
  • Contrel Europe
  • NEXT Life Sciences
  • Femasys Inc.
  • Apothecus Pharmaceutical
  • Sebela Pharmaceuticals (Sebela Women's Health)
  • FemCap Inc.
  • Mona Lisa N.V.
  • Okamoto Industries, Inc.
  • Fuji Latex Co., Ltd.
  • Veru Inc.

Conclusion & Analyst Recommendations